Tuesday, March 08, 2022 7:17:33 AM
THC Therapeutics always "operated" for the benefit of Brandon Romanek. I use the term "operate" loosely because the company never did much in the way of operating. While it did have a product, bringing that product to market was never a focus for Brandon. His focus was to raise capital, through the company, to provide for his lifestyle.
I do believe Brandon will attempt to make a few more moves, none of them focused on benefiting shareholders, that will lead to his ultimate demise.
We are watching for those moves.
The Game's the Same but the Rules Have Changed.
Recent THCT News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 09:20:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2024 04:58:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/08/2024 06:41:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:15:39 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM